Clinical Trial Detail

NCT ID NCT03877055
Title A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

mantle cell lymphoma

Therapies

Copanlisib + Ibrutinib

Ibrutinib

Age Groups: senior adult

No variant requirements are available.